Related references
Note: Only part of the references are listed.Biochemical and molecular characterization of tyrosine hydroxylase deficiency in Hong Kong Chinese
C. M. Mak et al.
MOLECULAR GENETICS AND METABOLISM (2010)
The pediatric neurotransmitter disorders
Phillip L. Pearl et al.
JOURNAL OF CHILD NEUROLOGY (2007)
Galactorrhea - A strong clinical clue towards the diagnosis of neurotransmitter disease
WL Yeung et al.
BRAIN & DEVELOPMENT (2006)
Dopa-responsive dystonia due to mild tyrosine hydroxylase deficiency
Y Furukawa et al.
ANNALS OF NEUROLOGY (2004)
Tyrosine hydroxylase deficiency causes progressive encephalopathy and dopa-nonresponsive dystonia
GF Hoffmann et al.
ANNALS OF NEUROLOGY (2003)
Tyrosine hydroxylase deficiency: Clinical manifestations of catecholamine insufficiency in infancy
PJ Grattan-Smith et al.
MOVEMENT DISORDERS (2002)
Atypical presentation of dopa-responsive dystonia: Generalized hypotonia and proximal weakness
CK Kong et al.
NEUROLOGY (2001)
L-dopa and selegiline for tyrosine hydroxylase deficiency
M Häussler et al.
JOURNAL OF PEDIATRICS (2001)
Dope-responsive dystonia simulating spastic paraplegia due to tyrosine hydroxylase (TH) gene mutations
Y Furukawa et al.
NEUROLOGY (2001)
L-dopa-responsive infantile hypokinetic rigid parkinsonism due to tyrosine hydroxylase deficiency
JF de Rijk-van Andel et al.
NEUROLOGY (2000)
Tyrosine hydroxylase deficiency with severe clinical course:: Clinical and biochemical investigations and optimization of therapy
C Dionisi-Vici et al.
JOURNAL OF PEDIATRICS (2000)
Share Paper
